SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-036752
Filing Date
2024-12-05
Accepted
2024-12-05 07:12:26
Documents
14
Period of Report
2024-12-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20241205_8k.htm   iXBRL 8-K 29321
  Complete submission text file 0001437749-24-036752.txt   166019

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20241202.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20241202_def.xml EX-101.DEF 11808
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20241202_lab.xml EX-101.LAB 15859
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20241202_pre.xml EX-101.PRE 12023
16 EXTRACTED XBRL INSTANCE DOCUMENT wint20241205_8k_htm.xml XML 2938
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 241527818
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)